Analyst Ratings for ResMed (RMD)
RMD Rating Summary
RMD Price Target Summary
- Highest: $345.00 (UBS)
- Lowest: $265.00 (Stifel)
- Average: $299.64
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$299.64 (+18.5%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 59%
Avg. $ Target:
$299.64 (+18.5%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 59%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/16/2025 | Baird » Updated 2/2/2026 |
Jeff Johnson | Downgrade | Neutral (Outperform) |
281.00 (275.00) |
252.27 (252.87) |
0.24% | Details |
| 9/18/2025 | Citi | Laura Sutcliffe | New Coverage | Buy (N/A) |
330.00 (N/A) |
271.71 (252.87) |
-6.93% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
